View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind...

Flash note: On the up

Recent positive developments at Snoozebox are headed by the current launch of the potentially transformative next-generation hotel product and access to significant new funding to accelerate growth plans. A more effective operating model is already evident in a sharp improvement in H1 pre-exceptional EBITDA thanks to stronger controls, a successful 2014 events season and a strengthening of senior management. 2015 events room sales are well ahead of last year, while the new Premier Oil workforce ...

Initiation: Rooms with a view

Snoozebox has a step change opportunity with the proposed launch of its next-generation hotel product, which has the potential to transform operating performance on significantly more efficient deployment and yield management. Meanwhile, booking rates for key events are materially ahead of last year and new high-profile deployments at Glastonbury and the Ryder Cup bring welcome visibility. Stronger financial controls underpin a sharp improvement in expected H1 pre-exceptional EBITDA.

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch